Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations

Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.

IIvan Liachko PPhase Genomics UUniversity of Washington